MINOVIA

Minovia Therapeutics is the first clinical stage company to use mitochondrial transplantation approach with the hope to bring life changing therapies to people suffering from mitochondrial dysfunction... We strive to be a global leader in the development of novel mitochondrial cell therapies to treat people stricken with diseases of mitochondrial dysfunction. Every day, together with the world's leading scientists, clinicians, and patient advocacy groups, we are translating our mitochondrial science into meaningful therapies for multiple disorders associated with mitochondrial dysfunction... Our ability to execute is driven by our highly experienced executive team, comprehensive regulatory strategy and clinical development plan in partnerships with key physicians and advisors.

Also known as: Minovia Therapeutics, Minovia Therapeutics LTD.